L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
iTBS+D-Cycloserine for Youth Suicide
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 54
- Registration Number
- NCT06121284
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
- Conditions
- Interventions
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 186
- Registration Number
- NCT06081361
- Locations
- 🇨🇳
The 8th Medical Center of Chinese Pla General Hospital, Beijing, China
🇨🇳Hebei Chest Hospital, Shijiazhuang, Hebei, China
🇨🇳Harbin Chest Hospital, Harbin, Heilongjiang, China
Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine
- Conditions
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Rose Research Center, LLC
- Target Recruit Count
- 25
- Registration Number
- NCT05994703
- Locations
- 🇺🇸
Rose Research Center, Raleigh, North Carolina, United States
D-Cycloserine+iTBS PK Study
- Conditions
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 12
- Registration Number
- NCT05731323
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)
- Conditions
- Interventions
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- The Alfred
- Target Recruit Count
- 180
- Registration Number
- NCT05591677
- Locations
- 🇦🇺
Monash Alfred Psychiatry Research Centre, Melbourne, Victoria, Australia
iTBS-DCS in Fibromyalgia
- Conditions
- Interventions
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 90
- Registration Number
- NCT05395494
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
- Conditions
- Interventions
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Beijing Chest Hospital
- Target Recruit Count
- 212
- Registration Number
- NCT05306223
- Locations
- 🇨🇳
Beijing Chest Hospital, Beijing, China
🇨🇳The Pulmonary Hospital of Fuzhou in Fujian Province（The tuberculosis control and prevention Hospital of Fuzhou in Fujian Province）, Fuzhou, China
🇨🇳The Eighth Medical Center of PLA General Hospital, Beijing, China
iTBS-DCS in Obsessive Compulsive Disorder
- Conditions
- Interventions
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 81
- Registration Number
- NCT05177601
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Repeated iTBS Cycloserine Motor Plasticity
- Conditions
- Interventions
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 20
- Registration Number
- NCT05081986
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Pain, Learning, and Nocebo
- Conditions
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 53
- Registration Number
- NCT04762836
- Locations
- 🇳🇱
Leiden University, Leiden, South Holland, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.